388 related articles for article (PubMed ID: 32024405)
1. Inter-reader agreement of interpretation of radiological course of bile duct changes between serial follow-up magnetic resonance imaging/3D magnetic resonance cholangiopancreatography of patients with primary sclerosing cholangitis.
Grigoriadis A; Morsbach F; Voulgarakis N; Said K; Bergquist A; Kartalis N
Scand J Gastroenterol; 2020 Feb; 55(2):228-235. PubMed ID: 32024405
[No Abstract] [Full Text] [Related]
2. Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret.
Zenouzi R; Liwinski T; Yamamura J; Weiler-Normann C; Sebode M; Keller S; Lohse AW; Schramm C;
Aliment Pharmacol Ther; 2018 Jul; 48(2):169-178. PubMed ID: 29741240
[TBL] [Abstract][Full Text] [Related]
3. Development of a prognostic MRCP-score (DiStrict) for individuals with large-duct primary sclerosing cholangitis.
Grigoriadis A; Imeen Ringe K; Bengtsson J; Baubeta E; Forsman C; Korsavidou-Hult N; Rorsman F; Nilsson E; Kartalis N; Bergquist A
JHEP Rep; 2022 Dec; 4(12):100595. PubMed ID: 36444388
[TBL] [Abstract][Full Text] [Related]
4. Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group.
Venkatesh SK; Welle CL; Miller FH; Jhaveri K; Ringe KI; Eaton JE; Bungay H; Arrivé L; Ba-Ssalamah A; Grigoriadis A; Schramm C; Fulcher AS;
Eur Radiol; 2022 Feb; 32(2):923-937. PubMed ID: 34363134
[TBL] [Abstract][Full Text] [Related]
5. The role of magnetic resonance imaging and endoscopic retrograde cholangiography in the evaluation of disease activity and severity in primary sclerosing cholangitis.
Tenca A; Mustonen H; Lind K; Lantto E; Kolho KL; Boyd S; Arola J; Jokelainen K; Färkkilä M
Liver Int; 2018 Dec; 38(12):2329-2339. PubMed ID: 29901259
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional magnetic resonance cholangiopancreatography with respiratory triggering in the diagnosis of primary sclerosing cholangitis: comparison with endoscopic retrograde cholangiography.
Textor HJ; Flacke S; Pauleit D; Keller E; Neubrand M; Terjung B; Gieseke J; Scheurlen C; Sauerbruch T; Schild HH
Endoscopy; 2002 Dec; 34(12):984-90. PubMed ID: 12471543
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging features of small-duct primary sclerosing cholangitis.
Kozaka K; Sheedy SP; Eaton JE; Venkatesh SK; Heiken JP
Abdom Radiol (NY); 2020 Aug; 45(8):2388-2399. PubMed ID: 32417935
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance cholangiopancreatography in the diagnosis of primary sclerosing cholangitis.
Weber C; Kuhlencordt R; Grotelueschen R; Wedegaertner U; Ang TL; Adam G; Soehendra N; Seitz U
Endoscopy; 2008 Sep; 40(9):739-45. PubMed ID: 18698533
[TBL] [Abstract][Full Text] [Related]
9. A Quantitative Magnetic Resonance Cholangiopancreatography Metric of Intrahepatic Biliary Dilatation Severity Detects High-Risk Primary Sclerosing Cholangitis.
Selvaraj EA; Ba-Ssalamah A; Poetter-Lang S; Ridgway GR; Brady JM; Collier J; Culver EL; Bailey A; Pavlides M
Hepatol Commun; 2022 Apr; 6(4):795-808. PubMed ID: 34802195
[TBL] [Abstract][Full Text] [Related]
10. Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis.
Villard C; Friis-Liby I; Rorsman F; Said K; Warnqvist A; Cornillet M; Kechagias S; Nyhlin N; Werner M; Janczewska I; Hagström T; Nilsson E; Bergquist A
J Hepatol; 2023 Mar; 78(3):604-613. PubMed ID: 36410555
[TBL] [Abstract][Full Text] [Related]
11. [MRCP in primary sclerosing cholangitis].
Weber C; Krupski G; Lorenzen J; Grotelüschen R; Seitz U; Rogiers X; Adam G
Rofo; 2003 Feb; 175(2):203-10. PubMed ID: 12584620
[TBL] [Abstract][Full Text] [Related]
12. Imaging of the murine biliopancreatic tract at 7 Tesla: technique and results in a model of primary sclerosing cholangitis.
Ernst TM; Schwinge D; Raabe N; Daubmann A; Kaul MG; Adam G; Schramm C; Ittrich H
J Magn Reson Imaging; 2014 Dec; 40(6):1355-64. PubMed ID: 24227696
[TBL] [Abstract][Full Text] [Related]
13. Differentiating pediatric autoimmune liver diseases by quantitative magnetic resonance cholangiopancreatography.
Gilligan LA; Trout AT; Lam S; Singh R; Tkach JA; Serai SD; Miethke AG; Dillman JR
Abdom Radiol (NY); 2020 Jan; 45(1):168-176. PubMed ID: 31422438
[TBL] [Abstract][Full Text] [Related]
14. Clinical Feasibility of 3-Dimensional Magnetic Resonance Cholangiopancreatography Using Compressed Sensing: Comparison of Image Quality and Diagnostic Performance.
Yoon JH; Lee SM; Kang HJ; Weiland E; Raithel E; Son Y; Kiefer B; Lee JM
Invest Radiol; 2017 Oct; 52(10):612-619. PubMed ID: 28448309
[TBL] [Abstract][Full Text] [Related]
15. Intrahepatic cystic biliary dilatation constitutes a significant prognostic factor in patients with primary sclerosing cholangitis.
Nguyen L; Cazzagon N; Corpechot C; El Mouhadi S; Lemoinne S; Chazouillères O; Arrivé L
Eur Radiol; 2019 Mar; 29(3):1460-1468. PubMed ID: 30159619
[TBL] [Abstract][Full Text] [Related]
16. Quantitative magnetic resonance cholangiopancreatography metrics are associated with disease severity and outcomes in people with primary sclerosing cholangitis.
Cazzagon N; El Mouhadi S; Vanderbecq Q; Ferreira C; Finnegan S; Lemoinne S; Corpechot C; Chazouillères O; Arrivé L
JHEP Rep; 2022 Nov; 4(11):100577. PubMed ID: 36277957
[TBL] [Abstract][Full Text] [Related]
17. MR and MRCP in the evaluation of primary sclerosing cholangitis: current applications and imaging findings.
Elsayes KM; Oliveira EP; Narra VR; Abou El Abbass HA; Ahmed MI; Tongdee R; Brown JJ
J Comput Assist Tomogr; 2006; 30(3):398-404. PubMed ID: 16778613
[TBL] [Abstract][Full Text] [Related]
18. Radiologic manifestations of sclerosing cholangitis with emphasis on MR cholangiopancreatography.
Vitellas KM; Keogan MT; Freed KS; Enns RA; Spritzer CE; Baillie JM; Nelson RC
Radiographics; 2000; 20(4):959-75; quiz 1108-9, 1112. PubMed ID: 10903686
[TBL] [Abstract][Full Text] [Related]
19. Correlation between findings on MRCP and gadolinium-enhanced MR of the liver and a survival model for primary sclerosing cholangitis.
Petrovic BD; Nikolaidis P; Hammond NA; Martin JA; Petrovic PV; Desai PM; Miller FH
Dig Dis Sci; 2007 Dec; 52(12):3499-506. PubMed ID: 17410447
[TBL] [Abstract][Full Text] [Related]
20. Fully automated detection of primary sclerosing cholangitis (PSC)-compatible bile duct changes based on 3D magnetic resonance cholangiopancreatography using machine learning.
Ringe KI; Vo Chieu VD; Wacker F; Lenzen H; Manns MP; Hundt C; Schmidt B; Winther HB
Eur Radiol; 2021 Apr; 31(4):2482-2489. PubMed ID: 32974688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
